John P. Evans

3.8k total citations · 3 hit papers
46 papers, 1.8k citations indexed

About

John P. Evans is a scholar working on Molecular Biology, Infectious Diseases and Cell Biology. According to data from OpenAlex, John P. Evans has authored 46 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Infectious Diseases and 7 papers in Cell Biology. Recurrent topics in John P. Evans's work include SARS-CoV-2 and COVID-19 Research (15 papers), COVID-19 Clinical Research Studies (8 papers) and Heme Oxygenase-1 and Carbon Monoxide (7 papers). John P. Evans is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (15 papers), COVID-19 Clinical Research Studies (8 papers) and Heme Oxygenase-1 and Carbon Monoxide (7 papers). John P. Evans collaborates with scholars based in United States, United Kingdom and Ireland. John P. Evans's co-authors include Shan‐Lu Liu, Linda J. Saif, Eugene M. Oltz, Judith P. Klinman, Yi-Min Zheng, Kyunghye Ahn, Cong Zeng, Richard J. Gumina, Claire Carlin and Gerard Lozanski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

John P. Evans

46 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2

2022 158 citations Panke Qu, John P. Evans et al. Cell Host & Microbe profile →
Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection

2022 133 citations John P. Evans, Cong Zeng et al. profile →
Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants

2023 96 citations Panke Qu, Julia N. Faraone et al. Cell Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John P. Evans United States	19	808	737	246	190	176	46	1.8k
Chih-chin Huang United States	12	331 0.4×	944 1.3×	192 0.8×	286 1.5×	64 0.4×	13	2.0k
Chi‐Yuan Chou Taiwan	28	779 1.0×	956 1.3×	232 0.9×	101 0.5×	23 0.1×	54	2.0k
Michael G. Natchus United States	29	1.0k 1.2×	879 1.2×	531 2.2×	120 0.6×	74 0.4×	69	2.9k
Jennifer Y. Chang United States	19	443 0.5×	611 0.8×	93 0.4×	217 1.1×	29 0.2×	41	1.6k
Samuel Constant Switzerland	25	397 0.5×	271 0.4×	80 0.3×	133 0.7×	142 0.8×	84	1.8k
John R. Rubin United States	25	260 0.3×	1.7k 2.2×	382 1.6×	260 1.4×	76 0.4×	77	2.9k
Lokesh Gakhar United States	26	235 0.3×	1.3k 1.7×	140 0.6×	174 0.9×	182 1.0×	60	2.2k
Stéfano Ricagno Italy	28	220 0.3×	1.4k 1.9×	167 0.7×	108 0.6×	33 0.2×	83	2.0k
Anita Changela United States	19	166 0.2×	900 1.2×	166 0.7×	189 1.0×	52 0.3×	23	1.6k

Countries citing papers authored by John P. Evans

Since Specialization

Citations

This map shows the geographic impact of John P. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Evans more than expected).

Fields of papers citing papers by John P. Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Evans. The network helps show where John P. Evans may publish in the future.

Co-authorship network of co-authors of John P. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Evans. A scholar is included among the top collaborators of John P. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Evans. John P. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Evans, John P. & Shan‐Lu Liu. (2023). Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies. The Journal of Immunology. 211(10). 1459–1467. 9 indexed citations

Qu, Panke, John P. Evans, Chaitanya Kurhade, et al.. (2023). Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants. mBio. 14(1). e0317622–e0317622. 18 indexed citations

Grant, Emma K., Sophie M. Bertrand, Kenneth Down, et al.. (2023). Covalent targeting of non-cysteine residues in PI4KIIIβ. RSC Chemical Biology. 4(12). 1111–1122. 3 indexed citations

Kenney, Adam D., Ashley Zani, John P. Evans, et al.. (2023). Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology. The Journal of Immunology. 210(9). 1257–1271. 7 indexed citations

Qu, Panke, Julia N. Faraone, John P. Evans, et al.. (2023). Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants. Cell Reports. 42(5). 112443–112443. 96 indexed citations breakdown →

Qu, Panke, John P. Evans, Julia N. Faraone, et al.. (2022). Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2. Cell Host & Microbe. 31(1). 9–17.e3. 158 indexed citations breakdown →

Qu, Panke, John P. Evans, Yi-Min Zheng, et al.. (2022). Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant. Cell Host & Microbe. 30(11). 1518–1526.e4. 59 indexed citations

Law, Robert P., João Nunes, Chun‐wa Chung, et al.. (2021). Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs. Angewandte Chemie International Edition. 60(43). 23327–23334. 85 indexed citations

Law, Robert P., João Nunes, Chun‐wa Chung, et al.. (2021). Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs. Angewandte Chemie. 133(43). 23515–23522. 4 indexed citations

10.

Zeng, Cong, John P. Evans, Tiffany King, et al.. (2021). SARS-CoV-2 spreads through cell-to-cell transmission. Proceedings of the National Academy of Sciences. 119(1). 154 indexed citations

11.

Evans, John P. & Shan‐Lu Liu. (2021). Role of host factors in SARS-CoV-2 entry. Journal of Biological Chemistry. 297(1). 100847–100847. 59 indexed citations

12.

Zeng, Cong, John P. Evans, Julia N. Faraone, et al.. (2021). Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H. mBio. 12(5). e0251021–e0251021. 27 indexed citations

13.

Lee, Kyuha, John P. Evans, Sriram Satagopan, et al.. (2020). Carbon Footprint of Biomimetic Carbon Fixation by Immobilizing Nature’s CO₂-sequestering Enzyme and Regenerating Its Energy Carrier. ACS Sustainable Chemistry & Engineering. 8(45). 16833–16841. 8 indexed citations

14.

Redmond, Joanna M., Andrei Mihut, Malini Menon, et al.. (2020). Hi-JAK-ing the ubiquitin system: The design and physicochemical optimisation of JAK PROTACs. Bioorganic & Medicinal Chemistry. 28(5). 115326–115326. 55 indexed citations

15.

Evans, John P., Antonia J. Lewis, Laurie Gordon, et al.. (2019). Cellular Target Engagement Approaches to Monitor Epigenetic Reader Domain Interactions. SLAS DISCOVERY. 25(2). 163–175. 6 indexed citations

16.

Rizzo, Michael J., John P. Evans, Morgan A. Burt, Cecil J. Saunders, & Erik C. Johnson. (2018). Unexpected role of a conserved domain in the first extracellular loop in G protein-coupled receptor trafficking. Biochemical and Biophysical Research Communications. 503(3). 1919–1926. 7 indexed citations

17.

Evans, John P., et al.. (2008). Isoporphyrin Intermediate in Heme Oxygenase Catalysis. Journal of Biological Chemistry. 283(28). 19530–19539. 29 indexed citations

18.

Evans, John P., et al.. (2007). Motexafin gadolinium - Apoptosis inducer, radiation enhancer, thioredoxin reductase inhibitor, ribonucleotide reductase inhibitor. Drugs of the Future. 32(7). 601–606. 3 indexed citations

19.

Evans, John P., Fengyun Xu, Mint Sirisawad, et al.. (2006). Motexafin Gadolinium-Induced Cell Death Correlates with Heme oxygenase-1 Expression and Inhibition of P450 Reductase-Dependent Activities. Molecular Pharmacology. 71(1). 193–200. 13 indexed citations

20.

Wang, Lixin, Baljit Walia, John P. Evans, et al.. (2003). IL-6 Induces NF-κB Activation in the Intestinal Epithelia. The Journal of Immunology. 171(6). 3194–3201. 193 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact